| 000 | 01091cam a2200301 a 4500 | ||
|---|---|---|---|
| 001 | 3924746 | ||
| 003 | BD-DhUL | ||
| 005 | 20150224103401.0 | ||
| 008 | 860827m19679999nyua b 001 0 eng | ||
| 010 | _a 66029495 | ||
| 035 | _a(OCoLC)779864 | ||
| 035 | _a(OCoLC)ocm00779864 | ||
| 035 | _a(CStRLIN)NYCM86-B5105 | ||
| 035 | _a(NNC)3924746 | ||
| 040 |
_aDLC _cMNU-B _dMdBJ _dNNC-M _dBD-DhUL |
||
| 050 | 0 |
_aRC267 _b.B83 |
|
| 082 |
_a616.99407 _bBUM |
||
| 100 | 1 | _aBusch, Harris. | |
| 245 | 1 | 0 |
_aMethods in cancer research : _bvol. 2 / _cedited by Harris Busch. |
| 260 |
_aNew York : _bAcademic Press, _cc1967. |
||
| 300 |
_axvi, 720 p. : _bill. ; _c24 cm. |
||
| 365 |
_aGBP _b13.96 |
||
| 504 | _aIncludes bibliographical references and index. | ||
| 505 | 0 | _av. 16-17. Cancer drug development, pt. A-B, edited by Vincent T. DeVita, and Harris Busch. 2 v.--v. 18. Oncodevelopmental antigens, edited by William H. Fishman and Harris Busch.--v. 19-20. Tumor markers, edited by Harris Busch and Lynn C. Yeoman. 2 v. | |
| 650 | 2 | _aNeoplasms. | |
| 650 | 2 | _aResearch. | |
| 942 |
_2ddc _cBK |
||
| 999 |
_c33573 _d33573 |
||